Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.079 | 0.7 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.074 | 0.7 |
mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.069 | 0.7 |